| Typicality: | 0.364 |
| Saliency: | 0.267 |
| to ace inhibitors | 3 | transitive-object |
| during the administration period | 3 | temporal |
| to standard therapy of plasma exchange | 3 | other |
| placebo → be given in → addition | 5 |
| placebo → be → provided | 3 |
| negative | neutral | positive |
| 0.163 | 0.786 | 0.051 |
| Raw frequency | 8 |
| Normalized frequency | 0.267 |
| Modifier score | 0.500 |
| Perplexity | 128.898 |